Barclays Maintains Overweight on MetLife, Raises Price Target to $97
Benzinga Newsdesk 3 months ago
NewsPrice TargetAnalyst Ratings
Barclays analyst Alex Scott maintains MetLife (NYSE:MET) with a Overweight and raises the price target from $94 to $97.
Barclays analyst Alex Scott maintains MetLife (NYSE:MET) with a Overweight and raises the price target from $94 to $97.